論文 - 詳細
| RRC ID | 55996 |
|---|---|
| 著者 | Hirschfield H, Bian CB, Higashi T, Nakagawa S, Zeleke TZ, Nair VD, Fuchs BC, Hoshida Y. |
| タイトル | In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment. |
| ジャーナル | Exp Mol Med |
| Abstract |
Tractable experimental model that accounts for inter-tumor molecular heterogeneity is a key element of anti-cancer drug development. Hepatocellular carcinoma is known to exhibit highly heterogeneous molecular aberrations across the tumors, including somatic genetic and epigenetic alterations. Previous studies showed that molecular tumor subtypes determined by transcriptome, as a comprehensive functional readout, are reproducibly observed across global patient populations irrespective of geographic and etiological variations. Here we demonstrate that transcriptomic hepatocellular carcinoma subtypes, S1 and S2, determined by our previous transcriptome meta-analysis of multiple clinical hepatocellular carcinoma cohorts, are presented in a panel of hepatoma cell lines widely used by the research community. Interestingly, cell line that resembles gene expression pattern of S3 subtype, representing less aggressive tumors, was not identified in the panel. MYC pathway-activated S2-like cell lines showed higher sensitivity to a small molecule BET bromodomain inhibitor, (+)-JQ1, which has anti-MYC activity. These results support the use of hepatoma cell lines as models to evaluate molecular subtype-specific drug response, which is expected to lead to development of tailored, precision care of the patients with hepatocellular carcinoma. |
| 巻・号 | 50(1) |
| ページ | e419 |
| 公開日 | 2018-1-5 |
| DOI | 10.1038/emm.2017.164 |
| PII | emm2017164 |
| PMID | 29303513 |
| PMC | PMC5992986 |
| MeSH | Antineoplastic Agents / pharmacology Azepines / pharmacology Biomarkers, Tumor / genetics Carcinoma, Hepatocellular / drug therapy* Carcinoma, Hepatocellular / genetics* Cell Line, Tumor Drug Screening Assays, Antitumor / methods* Gene Expression Profiling / methods Humans Liver Neoplasms / drug therapy* Liver Neoplasms / genetics* Molecular Targeted Therapy Triazoles / pharmacology alpha-Fetoproteins / genetics beta Catenin / genetics |
| IF | 4.743 |
| 引用数 | 12 |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | X(Twitter) |
| 各媒体での言及数の合計 | 7 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | Hep G2 HuH-7 |